logo

For the Inventor, By the Inventor

Boxborough, MA, United States of America

David Wilson

LinkedIn

This inventor holds 8 USPTO granted patents and 9 published patent applications. Top assignee: Quanterix Corporation. Active years: 2019-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David Wilson. Retrieved from https://idiyas.com/inventor/david-wilson-kxp8fv1q

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 

% Patents Active = 87.5

Average Co-Inventor Count = 5.6

ph-index = 2

Forward Citations = 25(Granted Patents)


Location History:

  • Boxborough, MA (US) (2019 - 2022)
  • Billerica, MA (US) (2023)

Company Filing History:

goldMedal8 out of 29 
 
Quanterix Corporation
 patents

Years Active: 2019-2026

Loading Chart...
8 patents (USPTO):Explore Patents
1. 12571803 - Methods of producing bodily fluid samples containing an analytically quantified amount of phosphorylated tau protein (2026-03-10),
2. 12540950 - Methods of assaying phosphorylated tau protein in a sample (2026-02-03),
3. 12287343 - Quantification of neurofilament light chain in physiological samples (2025-04-29),
4. 12130294 - Quantification of biomarkers present in physiological samples (2024-10-29),
5. 12111324 - Quantification of biomarkers present in dried physiological samples (2024-10-08),
6. 11686730 - Quantitative antibody test (2023-06-27),
7. 11275092 - Methods of determining a treatment protocol for and/or a prognosis of a patient's recovery from a brain injury (2022-03-15),
8. 10393759 - Methods of determining a treatment protocol for and/or a prognosis of a patient's recovery from a brain injury (2019-08-27),

Title: Biography of Inventor David Wilson

Introduction: David Wilson is a prominent inventor based in Boxborough, MA (US). He has made significant contributions to the field of biomedical research, particularly in the development of immunoassays for detecting neurological conditions. With a total of six patents to his name, Wilson's work has advanced the understanding of various biomarkers in physiological samples.

Latest Patents: Among his latest patents is the "Quantification of neurofilament light chain in physiological samples." This patent relates to immunoassays for NF-L performed on liquid samples derived from physiological fluids such as venous blood. It aims to detect the presence or absence of a physiological condition by quantifying one or a combination of NF-L determinations at concentrations indicative of the condition. Another notable patent is the "Quantification of biomarkers present in physiological samples," which focuses on immunoassays for NF-L, GFAP, UCH L1, and Tau. This innovation also utilizes liquid samples from physiological fluids to detect conditions by quantifying these biomarkers.

Career Highlights: David Wilson has established himself as a key figure in his field through his innovative work at Quanterix Corporation. His research has been instrumental in developing diagnostic tools that enhance the detection of neurological disorders.

Collaborations: Throughout his career, Wilson has collaborated with esteemed colleagues, including Lei Chang and Edward Kevin Hrusovsky. These partnerships have foster

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…